The study enrolled 238 people with primary biliary cholangitis (PBC) and cholestatic pruritus, a medical term for relentless ...
Medpage Today on MSN5d
Managing Primary Biliary Cholangitis Progression and SymptomsOnce clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the ...
Interim results from the ongoing GLISTEN trial of linerixibat, GSK's targeted inhibitor of the ileal bile acid transporter ...
On Tuesday, GSK plc (NYSE:GSK) released the headline results of the GLISTEN global phase 3 trial evaluating linerixibat in ...
GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...
GSK (NYSE:GSK) said a Phase 3 study of its drug linerixibat in the treatment of relentless itching in patients with primary ...
Medpage Today on MSN4d
Primary Biliary Cholangitis Incidence and Prevalence GrowingPrimary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...
UK pharma major GSK today announced positive headline results of GLISTEN, the ongoing global Phase III clinical trial ...
Drugmaker GSK said on Tuesday that its linerixibat candidate had shown "positive" Phase III results in cholestatic pruritus ...
in adults with cholestatic pruritus associated with primary biliary cholangitis, a rare autoimmune liver disease. GLISTEN met its primary endpoint, with linerixibat resulting in an improvement in itch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback